Literature DB >> 12374784

Nitric oxide promotes intracellular calcium release from mitochondria in striatal neurons.

Thomas F W Horn1, Gerald Wolf, Steven Duffy, Samuel Weiss, Gerburg Keilhoff, Brian A MacVicar.   

Abstract

Overproduction of nitric oxide by NMDA receptor stimulation is implicated in calcium deregulation and neurodegeneration of striatal neurons. We investigated the involvement of nitric oxide (NO) in inducing intracellular calcium release and in modifying calcium transients evoked by NMDA. NO application (4-10 microM) reversibly and repeatedly increased the intracellular calcium concentration [Ca2+]i in Fura-2- or fluo-3-loaded cultured mouse striatal neurons. NO-induced [Ca2+]i responses persisted in the absence of extracellular calcium, indicating that Ca2+ was released from intracellular stores. The source of calcium was distinct from [Ca2+]i-activated (ruthenium red and ryanodine sensitive) or IP3-activated (thapsigargin-sensitive) Ca2+ stores and was not dependent on cGMP production because a cell permeant analog, 8-bromo-cGMP, did not increase basal [Ca2+]i. Glucose removal potentiated the NO-induced release of [Ca2+]i. In contrast, pretreatment with either the mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone or cyclosporin A, a blocker of the mitochondrial permeability transition pore, prevented the [Ca2+]i increase after NO. The rise in [Ca2+]i during NO exposure was preceded by a decrease in mitochondrial membrane potential that was partly reversible during washout. Repeated applications of NMDA induced irreversible [Ca2+]i responses in a subpopulation of striatal cells that were greatly reduced by the NOS inhibitor N omega-nitro-l-arginine. Calcium transients were prolonged by conjoint application of NMDA and NO. We conclude that NMDA-evoked [Ca2+]i transients are modulated by endogenous NO production, which leads to release of calcium from the mitochondrial pool. An NO-activated mitochondrial permeability transition pore may lead to cell death after overstimulation of NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374784     DOI: 10.1096/fj.02-0126com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.

Authors:  Jamie Bellamy; Elizabeth J Bowen; Andrew F Russo; Paul L Durham
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

2.  The relation of different-scale membrane processes under nitric oxide influence.

Authors:  Nadiya A Brazhe Ulyanova; Liudmila A Erokhova; Anatolii A Churin; Georgy V Maksimov
Journal:  J Biol Phys       Date:  2005-12       Impact factor: 1.365

3.  Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus.

Authors:  De-Pei Li; Shao-Rui Chen; Thomas F Finnegan; Hui-Lin Pan
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

4.  Exogenous sphingosine 1-phosphate protects murine splenocytes against hypoxia-induced injury.

Authors:  Sonam Chawla; Chayanika Sahni; Rajkumar Tulsawani; Mrinalini Singh; Deepika Saraswat; Anju Bansal; Shweta Saxena
Journal:  Lipids       Date:  2013-11-05       Impact factor: 1.880

5.  Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.

Authors:  Jing Fan; Catherine M Cowan; Lily Y J Zhang; Michael R Hayden; Lynn A Raymond
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

6.  Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis.

Authors:  A Ghanizadeh
Journal:  Mol Syndromol       Date:  2011-10-12

7.  Methylmercury alters the activities of Hsp90 client proteins, prostaglandin E synthase/p23 (PGES/23) and nNOS.

Authors:  Samuel Caito; Heng Zeng; Judy L Aschner; Michael Aschner
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

8.  Deregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide.

Authors:  Nicolas Marsollier; Nadim Kassis; Karima Mezghenna; Maud Soty; Xavier Fioramonti; Amélie Lacombe; Aurélie Joly; Bruno Pillot; Carine Zitoun; José Vilar; Gilles Mithieux; René Gross; Anne-Dominique Lajoix; Vanessa Routh; Christophe Magnan; Céline Cruciani-Guglielmacci
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

9.  Potential Role of Caffeine in the Treatment of Parkinson's Disease.

Authors:  Mohsin H K Roshan; Amos Tambo; Nikolai P Pace
Journal:  Open Neurol J       Date:  2016-07-26

10.  The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Ilona Uzieliene; Eiva Bernotiene; Greta Rakauskiene; Jaroslav Denkovskij; Edvardas Bagdonas; Zygmunt Mackiewicz; Narunas Porvaneckas; Giedrius Kvederas; Ali Mobasheri
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.